Change - Announcement of Cessation::Cessation of Sho Kian Hin as Independent Director

Issuer & Securities

Issuer/ Manager
QUANTUM HEALTHCARE LIMITED
Securities
QUANTUM HEALTHCARE LIMITED - SGXE57350022 - V8Y
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
05-Nov-2024 21:13:58
Status
New
Announcement Sub Title
Cessation of Sho Kian Hin as Independent Director
Announcement Reference
SG241105OTHR9H9L
Submitted By (Co./ Ind. Name)
Thomas Tan Gim Chua
Designation
Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Announcement on cessation of Sho Kian Hin as Independent Director of Quantum Healthcare Limited.

This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the Sponsor is Ms Lim Hui Ling, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details

Name Of Person
Sho Kian Hin
Age
55
Is effective date of cessation known?
Yes
If yes, please provide the date
05/11/2024
Detailed Reason (s) for cessation
Mr Sho Kian Hin has served as an Independent Director of the Company for an aggregate period of 9 years (including his tenure in the Board of QT Vascular Ltd prior to the Group's restructuring). In view of the nine years tenure limit for Independent Directors prescribed under Catalist Rule 406(3)(d)(iv) of Singapore Exchange Securities Trading Limited (SGX-ST), Mr Sho Kian Hin has decided to step down to facilitate board renewal.

After having interviewed Mr Sho Kian Hin and to the best of its knowledge, the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that, save as disclosed in this announcement, there are no other material reasons for the cessation of Mr Sho Kian Hin as an Independent Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
30/05/2022
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director
Chairman of the Audit Committee (AC)
Member of the Remuneration Committee (RC)
Role and responsibilities
Independent Director, chairman of the AC and member of the RC.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
60 ordinary shares in the Company.
331,631 Share Awards under the QT Vascular Restricted Share Plan 2015.
Past (for the last 5 years)
1. MA China Medical Facilities Pte. Ltd.
2. MA Investment Holdings Pte. Ltd.
3. China Farm Equipment Pte Ltd
4. QT Vascular Ltd.
5. Versalink Holdings Limited.
6. Sim Leisure Group Ltd.
Present
1. Choo Chiang Holdings Ltd.
2. Hartanah Kencana Sdn Bhd
3. OUE Healthcare Limited
4. ISDN Holdings Ltd
5. JB Foods Limited
6. Figtree Holdings Ltd.